James Investment Research’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

James Investment Research’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,247	Closed	-$273K	–	516
2021 Q2	$273K	Hold	5,247	–	–	0.02%	264
2021 Q1	$240K	Sell	5,247 -380	-7%	-$18.6K	0.02%	266
2020 Q4	$259K	Hold	5,627	–	–	0.02%	245
2020 Q3	$219K	Hold	5,627	–	–	0.02%	249
2020 Q2	$214K	Buy	+5,627	New	+$190K	0.02%	243

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RCS

Retirement Capital Strategies San Jose, California $265M AUM 11.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SHJ

Sharkey, Howes & Javer Denver, Colorado $829M AUM 20.38% 1-Year Est. Return

PWP

Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return

James Investment Research's IDNA Position: Q3 2021 in Review

James Investment Research sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2021, closing a stake of 5,247 shares — an estimated $273K sold.

James Investment Research first reported a position in IDNA in Q2 2020 and held it in 5 quarters. The position peaked at $273K in Q2 2021. 89 funds tracked by Wall St. Rank hold IDNA as of Q3 2021.

James Investment Research reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2021 after selling out during the quarter.
James Investment Research sold 5,247 iShares Genomics Immunology and Healthcare ETF shares in Q3 2021, an estimated $273K.
James Investment Research first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and held it in 5 quarters.
James Investment Research's iShares Genomics Immunology and Healthcare ETF position peaked at $273K in Q2 2021.
89 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2021.

Based on James Investment Research's 13F filing for Q3 2021, filed 22 Oct 2021.